Beta-Modified Phosphoric Acid Precursor for Selective Reaction Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods are insufficient for selectively and efficiently inhibiting biological reactions caused by phosphorylation, particularly in processes like DNA replication and cholesterol synthesis, where specific and strong inhibition is needed.
Innovation Solution
A β-modified phosphoric acid compound precursor is developed, which, upon phosphorylation, generates an active species that specifically inhibits subsequent reactions by forming covalent bonds with biomolecules, thereby terminating the reaction process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional phosphorylation inhibitors are used, then some inhibition effect is achieved, but the inhibition is not sufficiently selective or efficient
Solution Approach 1:
The invention modifies the chemical structure of phosphoric acid compounds by introducing a β-modification (changing the spatial arrangement of atoms around the phosphorus atom). This structural parameter change creates compounds with specific stereochemistry that enables both high selectivity for target enzymes and high inhibition efficiency, resolving the contradiction between selective and efficient inhibition
Solution Approach 2:
The β-modification introduces a specific local structural feature (the spatial configuration around the phosphorus atom) that provides targeted interaction with enzyme active sites. This local structural quality enhancement allows the compound to selectively bind to specific phosphatases while maintaining strong inhibitory effect, achieving both selectivity and efficiency
2Reliability
If acyclovir is used as a DNA polymerase inhibitor, then viral DNA polymerase is competitively inhibited, but only DNA extension is inhibited and not other subsequent reactions
Solution Approach 1:
The β-modified phosphoric acid compounds are designed to inhibit multiple targets in the phosphorylation pathway, not just DNA polymerase. The compounds can inhibit various phosphatases including viral and host phosphatases, as well as enzymes in the mevalonate pathway. This multi-functional inhibition capability provides both broad specificity and strong inhibitory effect, overcoming the limitation of acyclovir which only inhibits DNA extension
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The β-modified phosphoric acid compound effectively and irreversibly inhibits targeted biological reactions, offering a more potent inhibition than existing compounds like acyclovir, with potential applications in treating diseases and conditions such as hepatitis B and hyperlipidemia.
Implementation Method 1
a β-modified phosphoric acid compound precursor to be phosphorylated by phosphorylation
Data Source
AI summary
A β-modified phosphoric acid compound precursor that inhibits the progress of a phosphorylation reaction having a partial structure represented bywhere A1 represents —SR1, —S—S—R1, —SeR1, or —X, where X is a halogen selected from fluoro, chloro, bromo, and iodo; R1 represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L1 represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L2 represents an alkyl group having 1 to 20 carbon atoms, or the like; L1 and L2 may be linked to each other to form a 4 to 6-membered ring structure; L1 and L2 may each have a substituent; and the symbol * represents a bond to be bonded to a phosphate group by phosphorylation. Further, provided are a reaction inhibitor and a medicine, each of which includes the β-modified phosphoric acid compound precursor.